Jane Li

Jane Li is the senior director of pharma CDx and CRO partnerships, clinical sequencing at Thermo Fisher Scientific, where she leads global strategy to expand the use of next-generation sequencing (NGS) in precision oncology. With over 20 years of experience in life sciences and diagnostics, she blends scientific expertise with business leadership to drive innovation. Li has helped launch and scale NGS-based oncology testing services, built key partnerships with pharma and cancer centers across the US and Asia, and led cross-functional teams in both large organizations and fast-paced startup environments. Her work focuses on turning complex science into real-world solutions that improve patient outcomes.